SE445173B - Oral, antihypertensiv komposition innehallande (d-3-merkapto-2-metylpropanoyl)-l-prolin och visst diuretikum - Google Patents

Oral, antihypertensiv komposition innehallande (d-3-merkapto-2-metylpropanoyl)-l-prolin och visst diuretikum

Info

Publication number
SE445173B
SE445173B SE7813277A SE7813277A SE445173B SE 445173 B SE445173 B SE 445173B SE 7813277 A SE7813277 A SE 7813277A SE 7813277 A SE7813277 A SE 7813277A SE 445173 B SE445173 B SE 445173B
Authority
SE
Sweden
Prior art keywords
proline
mercapto
methylpropanoyl
compound
diuretic
Prior art date
Application number
SE7813277A
Other languages
English (en)
Swedish (sv)
Other versions
SE7813277L (sv
Inventor
Z P Horovitz
B Rubin
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE445173(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE7813277L publication Critical patent/SE7813277L/xx
Publication of SE445173B publication Critical patent/SE445173B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7813277A 1977-12-27 1978-12-22 Oral, antihypertensiv komposition innehallande (d-3-merkapto-2-metylpropanoyl)-l-prolin och visst diuretikum SE445173B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27

Publications (2)

Publication Number Publication Date
SE7813277L SE7813277L (sv) 1979-06-28
SE445173B true SE445173B (sv) 1986-06-09

Family

ID=25343256

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7813277A SE445173B (sv) 1977-12-27 1978-12-22 Oral, antihypertensiv komposition innehallande (d-3-merkapto-2-metylpropanoyl)-l-prolin och visst diuretikum

Country Status (30)

Country Link
JP (1) JPS54110333A (fr)
AR (1) AR230378A1 (fr)
AU (1) AU526239B2 (fr)
BE (1) BE873092A (fr)
CA (1) CA1120400A (fr)
CH (1) CH642542A5 (fr)
DE (1) DE2854316C3 (fr)
DK (1) DK578778A (fr)
EG (1) EG14178A (fr)
FI (1) FI783991A (fr)
FR (1) FR2413089A1 (fr)
GB (1) GB2010675B (fr)
GR (1) GR72951B (fr)
HK (1) HK45483A (fr)
HU (1) HU178747B (fr)
IE (1) IE48306B1 (fr)
IL (1) IL56281A (fr)
IT (1) IT1202811B (fr)
KE (1) KE3235A (fr)
LU (1) LU80709A1 (fr)
MY (2) MY8300240A (fr)
NL (2) NL192870C (fr)
NO (1) NO784357L (fr)
NZ (1) NZ189159A (fr)
PH (1) PH22111A (fr)
PL (1) PL212188A1 (fr)
PT (1) PT68983A (fr)
SE (1) SE445173B (fr)
SG (1) SG41482G (fr)
ZA (1) ZA786948B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (fr) * 1995-02-10 1996-08-15 G.D. Searle & Co. Utilisation de faibles doses de spironolactone dans le traitement de maladies cardio-vasculaires

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
PH22111A (en) 1988-06-01
AR230378A1 (es) 1984-04-30
CA1120400A (fr) 1982-03-23
NZ189159A (en) 1984-12-14
GB2010675A (en) 1979-07-04
NL980017I1 (nl) 1998-07-01
IE782413L (en) 1979-06-27
AU4204178A (en) 1979-07-05
IT7831266A0 (it) 1978-12-22
NL7812164A (nl) 1979-06-29
IE48306B1 (en) 1984-12-12
PT68983A (en) 1979-01-01
IL56281A (en) 1983-05-15
KE3235A (en) 1982-11-05
NL192870C (nl) 1998-04-02
AU526239B2 (en) 1982-12-23
MY8300240A (en) 1983-12-31
DE2854316A1 (de) 1979-07-05
GR72951B (fr) 1984-01-17
NL192870B (nl) 1997-12-01
CH642542A5 (de) 1984-04-30
ZA786948B (en) 1980-04-30
HU178747B (en) 1982-06-28
FI783991A (fi) 1979-06-28
DK578778A (da) 1979-06-28
JPS54110333A (en) 1979-08-29
SE7813277L (sv) 1979-06-28
EG14178A (en) 1984-06-30
DE2854316C3 (de) 1994-12-22
BE873092A (fr) 1979-06-27
IL56281A0 (en) 1979-03-12
GB2010675B (en) 1982-06-16
NO784357L (no) 1979-06-28
HK45483A (en) 1983-10-28
SG41482G (en) 1985-01-11
LU80709A1 (de) 1979-04-13
FR2413089B1 (fr) 1980-12-26
PL212188A1 (fr) 1980-02-11
IT1202811B (it) 1989-02-09
MY102991A (en) 1993-03-31
FR2413089A1 (fr) 1979-07-27
DE2854316C2 (fr) 1989-08-10
JPS647045B2 (fr) 1989-02-07

Similar Documents

Publication Publication Date Title
US4217347A (en) Method of treating hypertension and medicaments therefor
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE68914292T2 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
EP1154777B1 (fr) Medicament pour le traitement de l'hypertension arterielle
SE445173B (sv) Oral, antihypertensiv komposition innehallande (d-3-merkapto-2-metylpropanoyl)-l-prolin och visst diuretikum
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
RU2298411C2 (ru) Применение экстрактов ginkgo biloba для получения лекарственного средства, предназначенного для лечения саркопении
EP0534907B1 (fr) Utilisation de dérivées de furanone pour prevenir ou traiter des maladies d'autoimmunité
DE3311922A1 (de) Antifibrotische mittel
DE69115528T2 (de) Neue pharmazeutische Verwendungen von Forskolin-Derivaten
DK165966B (da) Forbedret piroxicamholdigt anti-inflammatorisk praeparat
EP0471388B1 (fr) Médicament pour le traitement de l'insuffisance cardiaque
DE69200365T2 (de) Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria.
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
DE69910600T2 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
DE4002825C2 (de) Arzneistoffkombination aus einem Squalen-Synthetase-Inhibitor und einem anderen, das Serum-Cholesterin absenkenden Wirkstoff
KR100260479B1 (ko) 혈압강하용 복합제제
JPS6137731A (ja) グアバ葉エキスを有効成分とする経口糖尿病薬
Gitman et al. Effect of intravenously administered estrogen in cardiovascular disease
EP0129093A1 (fr) Utilisation du L-fucose dans la préparation d'un médicament pour inhalations et procédé de préparation du L-fucose
DE2618500A1 (de) Pharmazeutische zubereitung fuer die behandlung von bluthochdruck
JP2835547B2 (ja) 糖尿病治療剤
DE2820808A1 (de) Arzneimittel mit einer antanginoesen wirksamkeit
DE69427927T2 (de) Verwendung von Trimetazidin zur Herstellung von Medikamenten für die Behandlung von Gesundheitsstörungen, die durch die Nephrotoxizität von Cyclosporin A bedingt sind.
US3969525A (en) Method for reducing the heart beat frequency

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7813277

NAL Patent in force

Ref document number: 7813277-6

Format of ref document f/p: F

SPCG Supplementary protection certificate granted

Free format text: 9490190, 940617, EXPIRES: 20031222

NUG Patent has lapsed

Ref document number: 7813277-6

Format of ref document f/p: F